Boston Scientific to expand CRM footprint with Cameron Health buy

03/8/2012 | Wall Street Journal, The

Boston Scientific hopes to strengthen its foothold in the cardiac rhythm management market with the acquisition of Cameron Health, maker of the S-ICD wireless defibrillator. The deal calls for Boston Scientific to pay $150 million upfront in cash and possibly $150 million more upon FDA approval of the S-ICD system, plus as much as $1.05 billion in potential milestone payments during the course of the six years immediately after FDA approval.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY